Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
Go back to Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 149.66 -9.17 (5.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $158.83 | 52 Week High | $0.52 | |||
| Open | $154.20 | 52 Week Low | $0.08 | |||
| Day High | $156.13 | P/E | N/A | |||
| Day Low | $145.10 | EPS | $-3.80 | |||
| Volume | 21,997,276 | |||||
